You just read:

NMT Pharmaceuticals Singapore Announces Signing of Licensing Agreement with CAO Pharmaceuticals USA on Anti-cancer Drug CZ-48 and Initiation of Phase I Study

News provided by

NMT Pharmaceuticals

Apr 11, 2016, 08:00 ET